SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050843
Filing Date
2020-11-05
Accepted
2020-11-05 06:59:01
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-10q_20200930.htm 10-Q 2829609
2 EX-10.1 igms-ex101_89.htm EX-10.1 115048
3 EX-10.2 igms-ex102_90.htm EX-10.2 289702
4 EX-31.1 igms-ex311_8.htm EX-31.1 19010
5 EX-31.2 igms-ex312_7.htm EX-31.2 17505
6 EX-32.1 igms-ex321_6.htm EX-32.1 9509
7 EX-32.2 igms-ex322_9.htm EX-32.2 9504
  Complete submission text file 0001564590-20-050843.txt   7978161

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT igms-20200930.xml EX-101.INS 1364450
9 XBRL TAXONOMY EXTENSION SCHEMA igms-20200930.xsd EX-101.SCH 44726
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE igms-20200930_cal.xml EX-101.CAL 47400
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igms-20200930_def.xml EX-101.DEF 203482
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20200930_lab.xml EX-101.LAB 374726
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20200930_pre.xml EX-101.PRE 301843
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 201288583
SIC: 2834 Pharmaceutical Preparations